Literature DB >> 8781765

Aortic atherosclerosis in diabetes mellitus is associated with an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene. No relation between the polymorphism and aortic collagen content.

L M Rasmussen1, T Ledet.   

Abstract

An insertion(I)/deletion(D) polymorphism in the angiotensin I-converting enzyme (ACE) gene seems to be associated with clinical heart disease in patients with diabetes mellitus. It is not known whether increased atherosclerosis or other factors among individuals with certain ACE-gene subtypes form the basis for the increased prevalence of heart disease among these subjects. We measured, at autopsy, the extent of macroscopically visible aortic atherosclerosis in 22 diabetic and 39 non-diabetic subjects and determined the ACE-genotype of all individuals by the polymerase chain reaction. The percentage of aortic surface area covered with atherosclerotic lesions was 29 +/- 8 (n = 6), 71 +/- 7 (n = 9), and 65 +/- 7 (n = 5) in the II-, ID-, and DD-genotype subgroups, respectively, among diabetes patients (mean +/- SEM) (2 p < 0.01, when comparing values from the ID and DD groups to the II group). The values were 37 +/- 9 (n = 11), 40 +/- 5 (n = 14) and 37 +/- 6 (n = 11) in the II-, ID-, and DD-genotypes in the non-diabetic group. There were no differences in sex ratio or age in any of the ACE-gene subtypes. The previously described relationship between heart disease and the ACE-gene polymorphism in diabetes could thus be founded in an increased extent of atherosclerosis among patients with the ID- and DD-ACE-gene subtypes. Patients with diabetes have several alterations in the composition of the collagenous components in the arterial wall. We also analysed for associations between total collagen and type IV and type V collagen content in the aortic vessel wall and the ACE-gene subtypes. We were, however, not able to disclose correlations between the polymorphism and any of these parameters. In conclusion, our data show an association between the ACE-I/D polymorphism and the degree of aortic atherosclerosis in diabetes; however, we did not observe correlations between the polymorphism and data concerning arterial collagenous components.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781765     DOI: 10.1007/bf00418541

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.

Authors:  A V Chobanian; C C Haudenschild; C Nickerson; R Drago
Journal:  Hypertension       Date:  1990-03       Impact factor: 10.190

2.  Increased aortic stiffness in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  H Oxlund; L M Rasmussen; T T Andreassen; L Heickendorff
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

3.  Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

Authors:  H Itoh; M Mukoyama; R E Pratt; G H Gibbons; V J Dzau
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

4.  Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy.

Authors:  L Tarnow; F Cambien; P Rossing; F S Nielsen; B V Hansen; L Lecerf; O Poirier; S Danilov; S Boelskifte; K Borch-Johnsen
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

5.  Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM.

Authors:  T Fujisawa; H Ikegami; G Q Shen; E Yamato; K Takekawa; Y Nakagawa; Y Hamada; H Ueda; H Rakugi; J Higaki
Journal:  Diabetes Care       Date:  1995-07       Impact factor: 19.112

6.  Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells.

Authors:  B G Sharifi; D W LaFleur; C J Pirola; J S Forrester; J A Fagin
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

7.  Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications.

Authors:  M Marre; P Bernadet; Y Gallois; F Savagner; T T Guyene; M Hallab; F Cambien; P Passa; F Alhenc-Gelas
Journal:  Diabetes       Date:  1994-03       Impact factor: 9.461

8.  A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease.

Authors:  K Lindpaintner; M A Pfeffer; R Kreutz; M J Stampfer; F Grodstein; F LaMotte; J Buring; C H Hennekens
Journal:  N Engl J Med       Date:  1995-03-16       Impact factor: 91.245

9.  Diabetic macroangiopathy. Quantitative histopathological studies of the extramural coronary arteries from type 2 (non-insulin-dependent) diabetic patients.

Authors:  H Dybdahl; T Ledet
Journal:  Diabetologia       Date:  1987-11       Impact factor: 10.122

10.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).

Authors:  B Rigat; C Hubert; P Corvol; F Soubrier
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

View more
  2 in total

1.  Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphism.

Authors:  Halil Tanriverdi; Harun Evrengul; Hatice Mergen; Ceren Acar; Deniz Seleci; Omur Kuru; Seyhan Tanriverdi; Asuman Kaftan
Journal:  Heart Vessels       Date:  2007-01-26       Impact factor: 2.037

2.  Triterpenoids from the roots of Sanguisorba tenuifolia var. Alba.

Authors:  Hai-Xue Kuang; Hong-Wei Li; Qiu-Hong Wang; Bing-You Yang; Zhi-Bin Wang; Yong-Gang Xia
Journal:  Molecules       Date:  2011-06-03       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.